FVFIGP
Flagship Ventures Fund IV General Partner Portfolio holdings
AUM
$585M
This Quarter Return
+18.55%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$507M
AUM Growth
–
Cap. Flow
+$507M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Seres Therapeutics
MCRB
|
$494M |
| 2 |
TTOO
T2 Biosystems, Inc
TTOO
|
$8.12M |
| 3 |
Carisma Therapeutics
CARM
|
$4.41M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 98.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Seres Therapeutics
MCRB
$166M
| $494M | 97.53% |
+14,083,579
| New | +$494M |
|
|
TTOO
2
DELISTED
T2 Biosystems, Inc
TTOO
| $8.12M | 1.6% |
+741,755
| New | +$8.12M |
|
|
3
Carisma Therapeutics
CARM
$8.98M
| $4.41M | 0.87% |
+1,466,417
| New | +$4.41M |
|